Literature DB >> 22710191

Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice.

Deanna D Nguyen1, Marc-Andre Wurbel2, Jeremy A Goettel2, Michelle A Eston3, Osub S Ahmed4, Romela Marin3, Elisa K Boden5, Eduardo J Villablanca5, Helena Paidassi6, Vineet Ahuja5, Hans-Christian Reinecker5, Edda Fiebiger2, Adam Lacy-Hulbert6, Bruce H Horwitz7, J Rodrigo Mora5, Scott B Snapper8.   

Abstract

BACKGROUND & AIMS: Immunodeficiency and autoimmune sequelae, including colitis, develop in patients and mice deficient in Wiskott-Aldrich syndrome protein (WASP), a hematopoietic cell-specific intracellular signaling molecule that regulates the actin cytoskeleton. Development of colitis in WASP-deficient mice requires lymphocytes; transfer of T cells is sufficient to induce colitis in immunodeficient mice. We investigated the interactions between innate and adaptive immune cells in mucosal regulation during development of T cell-mediated colitis in mice with WASP-deficient cells of the innate immune system.
METHODS: Naïve and/or regulatory CD4(+) T cells were transferred from 129 SvEv mice into RAG-2-deficient (RAG-2 KO) mice or mice lacking WASP and RAG-2 (WRDKO). Animals were observed for the development of colitis; effector and regulatory functions of innate immune and T cells were analyzed with in vivo and in vitro assays.
RESULTS: Transfer of unfractionated CD4(+) T cells induced severe colitis in WRDKO, but not RAG-2 KO, mice. Naïve wild-type T cells had higher levels of effector activity and regulatory T cells had reduced suppressive function when transferred into WRDKO mice compared with RAG-2 KO mice. Regulatory T-cell proliferation, generation, and maintenance of FoxP3 expression were reduced in WRDKO recipients and associated with reduced numbers of CD103(+) tolerogenic dendritic cells and levels of interleukin-10. Administration of interleukin-10 prevented induction of colitis following transfer of T cells into WRDKO mice.
CONCLUSIONS: Defective interactions between WASP-deficient innate immune cells and normal T cells disrupt mucosal regulation, potentially by altering the functions of tolerogenic dendritic cells, production of interleukin-10, and homeostasis of regulatory T cells.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710191      PMCID: PMC3760724          DOI: 10.1053/j.gastro.2012.06.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease.

Authors:  Joshua D Milner; Jerrold M Ward; Andrea Keane-Myers; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

2.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

Authors:  Holm H Uhlig; Brent S McKenzie; Sophie Hue; Claire Thompson; Barbara Joyce-Shaikh; Renata Stepankova; Nicolas Robinson; Sofia Buonocore; Helena Tlaskalova-Hogenova; Daniel J Cua; Fiona Powrie
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

3.  WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo.

Authors:  Scott B Snapper; Parool Meelu; Deanna Nguyen; Britt M Stockton; Patricia Bozza; Frederick W Alt; Fred S Rosen; Ulrich H von Andrian; Christoph Klein
Journal:  J Leukoc Biol       Date:  2005-03-17       Impact factor: 4.962

4.  Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation.

Authors:  S Burns; A J Thrasher; M P Blundell; L Machesky; G E Jones
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein.

Authors:  Sofia de Noronha; Samantha Hardy; Joanna Sinclair; Michael P Blundell; Jessica Strid; Oliver Schulz; Jörg Zwirner; Gareth E Jones; David R Katz; Christine Kinnon; Adrian J Thrasher
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

6.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

7.  Ulcerative colitis in a patient with Wiskott-Aldrich syndrome.

Authors:  C Folwaczny; C Ruelfs; J Walther; A König; B Emmerich
Journal:  Endoscopy       Date:  2002-10       Impact factor: 10.093

8.  Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.

Authors:  Sophie Dupuis-Girod; Jacques Medioni; Elie Haddad; Pierre Quartier; Marina Cavazzana-Calvo; Françoise Le Deist; Geneviève de Saint Basile; Jean Delaunay; Klaus Schwarz; Jean-Laurent Casanova; Stephane Blanche; Alain Fischer
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

9.  Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.

Authors:  S B Snapper; F S Rosen; E Mizoguchi; P Cohen; W Khan; C H Liu; T L Hagemann; S P Kwan; R Ferrini; L Davidson; A K Bhan; F W Alt
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

10.  Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome.

Authors:  D Zicha; W E Allen; P M Brickell; C Kinnon; G A Dunn; G E Jones; A J Thrasher
Journal:  Br J Haematol       Date:  1998-06       Impact factor: 6.998

View more
  18 in total

1.  Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function.

Authors:  Dror S Shouval; Amlan Biswas; Jeremy A Goettel; Katelyn McCann; Evan Conaway; Naresh S Redhu; Ivan D Mascanfroni; Ziad Al Adham; Sydney Lavoie; Mouna Ibourk; Deanna D Nguyen; Janneke N Samsom; Johanna C Escher; Raz Somech; Batia Weiss; Rita Beier; Laurie S Conklin; Christen L Ebens; Fernanda G M S Santos; Alexandre R Ferreira; Mary Sherlock; Atul K Bhan; Werner Müller; J Rodrigo Mora; Francisco J Quintana; Christoph Klein; Aleixo M Muise; Bruce H Horwitz; Scott B Snapper
Journal:  Immunity       Date:  2014-05-01       Impact factor: 31.745

2.  Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis.

Authors:  Naomi L Ward; Caleb D Phillips; Deanna D Nguyen; Nanda Kumar N Shanmugam; Yan Song; Richard Hodin; Hai Ning Shi; Bobby J Cherayil; Allan M Goldstein
Journal:  Inflamm Bowel Dis       Date:  2016-10       Impact factor: 5.325

Review 3.  Very early-onset inflammatory bowel disease: gaining insight through focused discovery.

Authors:  Christopher J Moran; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

4.  Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome.

Authors:  Karla E Cervantes-Luevano; Nicoletta Caronni; Maria C Castiello; Elena Fontana; Giulia M Piperno; Asma Naseem; Paolo Uva; Marita Bosticardo; Genni E Marcovecchio; Luigi D Notarangelo; Maria P Cicalese; Alessandro Aiuti; Anna Villa; Federica Benvenuti
Journal:  J Allergy Clin Immunol       Date:  2018-02-13       Impact factor: 10.793

5.  Colitis and colon cancer in WASP-deficient mice require helicobacter species.

Authors:  Deanna D Nguyen; Suresh Muthupalani; Jeremy A Goettel; Michelle A Eston; Melissa Mobley; Nancy S Taylor; Amanda McCabe; Romela Marin; Scott B Snapper; James G Fox
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

6.  Transient activation of mucosal effector immune responses by resident intestinal bacteria in normal hosts is regulated by interleukin-10 signalling.

Authors:  Cong Wu; R Balfour Sartor; Kehe Huang; Susan L Tonkonogy
Journal:  Immunology       Date:  2016-07       Impact factor: 7.397

Review 7.  Gut microbiome and anticancer immune response: really hot Sh*t!

Authors:  S Viaud; R Daillère; I G Boneca; P Lepage; P Langella; M Chamaillard; M J Pittet; F Ghiringhelli; G Trinchieri; R Goldszmid; L Zitvogel
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

8.  Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease.

Authors:  Judith R Kelsen; Robert N Baldassano; David Artis; Gregory F Sonnenberg
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-09-01

Review 9.  Animal models of ulcerative colitis and their application in drug research.

Authors:  Daren Low; Deanna D Nguyen; Emiko Mizoguchi
Journal:  Drug Des Devel Ther       Date:  2013-11-12       Impact factor: 4.162

10.  Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.

Authors:  Francesca Prete; Marco Catucci; Mayrel Labrada; Stefania Gobessi; Maria Carmina Castiello; Elisa Bonomi; Alessandro Aiuti; William Vermi; Caterina Cancrini; Ayse Metin; Sophie Hambleton; Robbert Bredius; Luigi Daniele Notarangelo; Mirjam van der Burg; Ulrich Kalinke; Anna Villa; Federica Benvenuti
Journal:  J Exp Med       Date:  2013-01-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.